Allergy therapy by intranasal administration with recombinant Lactococcus lactis producing bovine β-lactoglobulin

International Archives of Allergy and Immunology

Volumn 150, Issue 1, 2009, Pages 25-31

  Cortes Perez, Naima G ^a,b   Ah Leung, Sandrine ^a   Bermúdez Humarán, Luis G ^b   Corthier, Gérard ^b   Langella, Philippe ^b   Wal, Jean Michel ^a   Adel Patient, Karine ^a,c  

^a Bâtiment 136 CEA de Saclay   (France)

^b CEMAGREF   (France)

^c CEA SACLAY   (France)

Author keywords

Lactoglobulin; Allergy therapy; Lactococcus lactis; Th1 Th2 balance

Indexed keywords

BETA LACTOGLOBULIN; CHOLERA TOXIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PROBIOTIC AGENT; RECOMBINANT BETA LACTOGLOBULIN; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COW; FEMALE; IMMUNOTHERAPY; LACTOCOCCUS LACTIS; LUNG LAVAGE; MILK; MILK ALLERGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STRAIN DIFFERENCE; TH1 CELL; TH2 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; CATTLE; DESENSITIZATION, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; LACTOCOCCUS LACTIS; LACTOGLOBULINS; MICE; MICE, INBRED BALB C; MILK HYPERSENSITIVITY;

EID: 63349085245     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210377     Document Type: Article

References (35)

1. European Commission Report T72: Scientific co-operation on questions relating to food: consideration of the epidemiological basis for appropriate measures for the protection of public health in respect to food allergy. Brussels, European Commission, 1998.
2. Crespo JF, Rodriguez J: Food allergy in adulthood. Allergy 2003; 58: 98-113.
3. Wal JM, Bernard H, Clement G, Chatel JM, Adel-Patient K: Characterization of allergens in milk. Curr Allergy Clin Immunol 2001; 14: 4-10.
4. Wal JM: Bovine milk allergenicity. Ann Allergy Asthma Immunol 2004; 93:S2-S11.
5. Host A: Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol 1994; 5: 1-36.
6. Schmidt-Weber CB, Akdis M, Akdis CA: TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120: 247-254.
7. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275-283. (Pubitemid 28188888)
8. Paludan S: Interleukin-4 and interferongamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol 1998; 48: 459-468.
9. Ostroukhova M, Seguin-Devaux C, Oriss TB, Dixon-McCarthy B, Yang L, Ameredes BT, Corcoran TE, Ray A: Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest 2004; 114: 28-38. (Pubitemid 39071641)
10. Miettinen M, Vuopio-Varkila J, Varkila K: Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64: 5403-5405. (Pubitemid 26404010)
11. Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-185. (Pubitemid 27091565)
12. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A: Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002; 110: 617-623. (Pubitemid 35178799)
13. Bermúdez-Humarán L, Corthier G, Langella P: Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines. Recent Res Devel Microbiology 2004; 8: 147-160.
14. Drouault S, Corthier G, Ehrlich SD, Renault P: Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 1999; 65: 4881-4886.
15. Kimoto H, Nomura M, Kobayashi M, Mizumachi K, Okamoto T: Survival of lactococci during passage through mouse digestive tract. Can J Microbiol 2003; 49: 707-711. (Pubitemid 38299732)
16. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L: A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 754-759. (Pubitemid 43841860)
17. Chatel JM, Langella P, Adel-Patient K, Commissaire J, Wal JM, Corthier G: Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin Diagn Lab Immunol 2001; 8: 545-551.
18. Chatel JM, Nouaille S, Adel-Patient K, Le Loir Y, Boe H, Gruss A, Wal JM, Langella P: Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice. Appl Environ Microbiol 2003; 69: 6620-6627.
19. Adel-Patient K, Ah-Leung S, Creminon C, Nouaille S, Chatel JM, Langella P, Wal JM: Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy 2005; 35: 539-546.
20. Cortes-Perez NG, Ah-Leung S, Bermúdez-Humarán
21. LG, Corthier G, Wal JM, Langella P, Adel-Patient K: Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin Vaccine Immunol 2007; 14: 226-233. (Pubitemid 46570276)
22. Nouaille S, Bermúdez-Humarán LG, Adel-Patient K, Commissaire J, Gruss A, Wal JM, Azevedo V, Langella P, Chatel JM: Improvement of bovine beta-lactoglobulin production and secretion by Lactococcus lactis. Braz J Med Biol Res 2005; 38: 353-359.
23. Adel-Patient K, Bernard H, Ah-Leung S, Créminon C, Wal JM: Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy 2005; 60: 658-664.
24. Adel-Patient K, Nahori MA, Proust B, Lapa e Silva JR, Creminon C, Wal JM, Vargaftig BB: Elicitation of the allergic reaction in beta-lactoglobulin- sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge. Clin Exp Allergy 2003; 33: 376-385. (Pubitemid 36315180)
25. Adel-Patient K, Creminon C, Bernard H, Clement G, Negroni L, Frobert Y, Grassi J, Wal JM, Chatel JM: Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice. J Immunol Methods 2000; 235: 21-32. (Pubitemid 30089780)
26. Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U: Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003; 22: 87-95. (Pubitemid 37357155)
27. Cortes-Perez NG, Lefèvre F, Corthier G, Adel-Patient K, Langella P, Bermúdez-Humarán LG: Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007; 25: 6581-6588.
28. Ratajczak C, Duez C, Grangette C, Pochard P, Tonnel AB, Pestel J: Impact of lactic acid bacteria on dendritic cells from allergic patients in an experimental model of intestinal epithelium. J Biomed Biotechnol 2007; 1: 71921. (Pubitemid 46410513)
29. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H, Wiedermann U, Mercenier A: Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006; 61: 812-819. (Pubitemid 43893983)
30. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183: 109-117.
31. Venkayya R, Lam M, Willkom M, Grünig G, Corry DB, Erle DJ: The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002; 26: 202-208. (Pubitemid 34107874)
32. Hanniffy SB, Carter AT, Hitchin E, Wells JM: Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 2007; 195: 185-193.
33. Abdul-Majid KB, Ly LH, Converse PJ, Geiman DE, McMurray DN, Bishai WR: Altered cellular infiltration and cytokine levels during early Mycobacterium tuberculosis sigC mutant infection are associated with latestage disease attenuation and milder immunopathology in mice. BMC Microbiol 2008; 17; 8: 151.
34. Cochran JR, Khan AM, Elidemir O, Xue H, Cua B, Fullmer J, Larsen GL, Colasurdo GN: Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002; 34: 267-277.
35. Zindler E, Gehrke N, Luft C, Reuter S, Taube C, Finotto S, Reske-Kunz AB, Sudowe S: Divergent effects of biolistic gene transfer in a mouse model of allergic airway inflammation. Am J Respir Cell Mol Biol 2008; 38: 38-46.